Biotech

Jim Cramer Likes UTX, Says Gilead Has Peaked, Sees a Bottom for Oil

Jim Cramer Likes UTX, Says Gilead Has Peaked, Sees a Bottom for Oil

DuPont Beats Earnings Ahead of Dow Chemical Merger

DuPont Beats Earnings Ahead of Dow Chemical Merger

Gilead Readying for Earnings Report

Gilead Readying for Earnings Report

What to Watch This Week: Apple, Facebook, Alphabet Report Earnings; Federal Reserve Meeting

What to Watch This Week: Apple, Facebook, Alphabet Report Earnings; Federal Reserve Meeting

Jim Cramer on Tesla: Elon Musk is a Visionary, Numbers Tell a Different Story

Jim Cramer on Tesla: Elon Musk is a Visionary, Numbers Tell a Different Story

Relypsa Stock Surges on $1.53 Billion Galenica Takeover Offer

Relypsa Stock Surges on $1.53 Billion Galenica Takeover Offer

Biogen Shares Climb on Earnings Beat, CEO Departure

Biogen Shares Climb on Earnings Beat, CEO Departure

Biogen CEO Resigns After Six Years of Boom-and-Bust Leadership

Biogen CEO Resigns After Six Years of Boom-and-Bust Leadership

13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys

13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys

Here's Why Jim Cramer Is Positive About Valeant Pharmaceuticals

Here's Why Jim Cramer Is Positive About Valeant Pharmaceuticals